Clinical trial · Interventional
Psychoeducation for Uveal Melanoma
Promoting Adjustment in Uveal Melanoma Survivorship: A Randomized Trial Targeting Illness Perceptions
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uveal Melanoma | Uveal Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Best Practice | Behavioral | — | UNRESOLVED |
| Education for Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Arm 1
- description
- Participants watch two fifteen-minute educational videos and receive a mental health resource information sheet on study.
- interventionNames
- Behavioral: Education for Intervention
- type
- EXPERIMENTAL
- label
- Arm II
- description
- Patients receive enhanced treatment as usual and receive a mental health resource information sheet on study.
- interventionNames
- Behavioral: Best Practice
Primary outcomes (3)
- measure
- Change in illness perceptions of disease control
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults (age 18 years and older at visit 1) * History of uveal melanoma as documented in their University of California, Los Angeles (UCLA) medical record * Receipt of uveal melanoma treatment and/or ongoing follow-up care at the UCLA Jules Stein Eye Institute, as documented in their UCLA medical record * Ability to read, write, and converse in English * Access to the internet via a computer or cell phone * Access to a personal email address * Written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study Exclusion Criteria: \-
References
Publications (0)
Data not yet available